M Ryks
Overview
Explore the profile of M Ryks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halawi H, Vijayvargiya P, Busciglio I, Oduyebo I, Khemani D, Ryks M, et al.
Neurogastroenterol Motil
. 2018 Feb;
30(5):e13298.
PMID: 29405492
Background: Nausea, vomiting, and constipation (OIC) are common adverse effects of acute or chronic opioid use. Naloxegol (25 mg) is an approved peripherally active mu-opiate opioid receptor antagonist. Aim: To...
2.
Nelson A, Camilleri M, Acosta A, Boldingh A, Busciglio I, Burton D, et al.
Neurogastroenterol Motil
. 2017 Feb;
29(7).
PMID: 28177172
Background: In an open-label study of 26 patients with IBS-C and chronic constipation, treatment with a vibrating (VIBRANT) capsule twice a week for 7.5 weeks resulted in 88.5% responders. Effects...
3.
Nelson A, Camilleri M, Acosta A, Busciglio I, Linker Nord S, Boldingh A, et al.
Neurogastroenterol Motil
. 2016 Jun;
28(11):1705-1713.
PMID: 27283792
Background: Synthetic human ghrelin accelerates gastric emptying, reduces gastric accommodation, and results in numerical increases in postprandial symptom scores. The ghrelin receptor agonist, relamorelin, accelerates gastric emptying in patients with...
4.
Grover M, Camilleri M, Hines J, Burton D, Ryks M, Wadhwa A, et al.
Neurogastroenterol Motil
. 2016 Feb;
28(7):1114-9.
PMID: 26914765
Background: Gastrointestinal (GI) and non-GI disorders are associated with altered intestinal permeability, which can be measured in vivo by urinary excretion after oral lactulose and mannitol ingestion. Inadvertent dietary consumption...
5.
Jeong I, Camilleri M, Shin A, Iturrino J, Boldingh A, Busciglio I, et al.
Aliment Pharmacol Ther
. 2012 Feb;
35(9):1088-96.
PMID: 22348605
Background: Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor. In clinical trials, tapentadol provided somatic pain relief comparable to mu-opioids such as oxycodone, with significantly less gastrointestinal adverse...
6.
Wong B, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, et al.
Neurogastroenterol Motil
. 2012 Feb;
24(4):358-e169.
PMID: 22288893
Background: Genetic variation in endocannabinoid metabolism is associated with colonic transit in irritable bowel syndrome (IBS) with diarrhea (IBS-D). The nonselective cannabinoid (CB) receptor agonist, dronabinol (DRO), reduced fasting colonic...
7.
Wong B, Rao A, Camilleri M, Manabe N, McKinzie S, Busciglio I, et al.
Aliment Pharmacol Ther
. 2010 Sep;
32(7):884-93.
PMID: 20839388
Background: The short-term effects of methylnaltrexone (MNTX), a peripherally acting mu-opioid receptor antagonist, on gastrointestinal and colonic transit remain unclear. Aim: To compare the effects of placebo, codeine, subcutaneous (s.c.)...
8.
Camilleri M, Nadeau A, Lamsam J, Linker Nord S, Ryks M, Burton D, et al.
Neurogastroenterol Motil
. 2009 Jul;
22(1):e15-26.
PMID: 19614866
Our aim was to understand the information from differential two-sugar excretion (2-SE) in measuring intestinal permeability. In a crossover study in 12 healthy volunteers, we compared urinary excretion ratios of...
9.
Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, et al.
Neurogastroenterol Motil
. 2009 Mar;
21(4):399-410.
PMID: 19309415
Adrenergic and serotonergic (ADR-SER) mechanisms alter gut (gastrointestinal, GI) sensorimotor functions. We aimed to determine whether candidate ADR-SER genes affect GI responses to low dose clonidine (CLO) in humans. Forty...
10.
Grudell A, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, et al.
Neurogastroenterol Motil
. 2007 Nov;
20(3):213-9.
PMID: 17971028
Adrenergic and serotonergic mechanisms alter human gut motor functions. Genotype variation influences phenotype. Our aim was to test the hypothesis that variation in genes that control these functions is associated...